Search bioRxiv⌕ Search

Biology subjects

Malavia-Jones, D.

Publications and source records attributed to Malavia-Jones, D..

2 recordsLinked to original sources

HOG pathway modulation is a determinant of echinocandin treatment failure in Candidozyma auris

Candidozyma auris is a rapidly emerging fungal pathogen whose drug-resistant profile poses a formidable challenge to antifungal treatment. Echinocandins are the recommended first-line therapy for invasive C. auris infections, but resistance to this drug class is on the rise. Here we show that, beyond resistance, C. auris can readily acquire genetically encoded echinocandin tolerance, a phenotype of slow but sustained growth and increased survival at concentrations above the minimum inhibitory concentration (MIC) that reflects incomplete maximal inhibition and a reduced Hill coefficient without an increase in MIC. Tolerance was therefore undetectable by standard clinical susceptibility testing, yet it significantly reduced treatment efficacy in an immunocompromised murine model of systemic infection. Genetic dissection revealed that tolerance arises through disruption of the high-osmolarity glycerol (HOG) mitogen-activated protein kinase (MAPK) pathway through the loss of function of Ssk1, Ssk2, Pbs2 or Hog1, or specific substitutions in Nik1. The disruption of the HOG pathway did not confer fitness or virulence defects in C. auris, and in Candida albicans and Nakaseomyces glabratus, it did not confer tolerance, suggesting a unique non-essential rewiring of this pathway in C. auris. Proteomic and cell-wall analyses linked tolerance to altered cell-wall remodelling during echinocandin exposure. Evolutionary modelling and deep sequencing of FKS1 hotspots in experimentally evolved populations showed that tolerance increases the rate at which resistance-conferring FKS1 hotspot substitutions emerge. Putative high-impact mutations in HOG pathway effectors in clinical isolates suggest that this phenotype occurs in patients, where it might reduce treatment efficacy or facilitate resistance emergence. This work therefore identifies HOG-mediated acquired tolerance as a hidden clinically relevant direct and indirect determinant of echinocandin treatment failure.

microbiology↗

Strain and temperature dependent aggregation of Candida auris is attenuated by inhibition of surface amyloid proteins

Candida auris is a multi-drug resistant human fungal pathogen that has become a global threat to human health due to its drug resistant phenotype, persistence in the hospital environment and propensity for patient to patient spread. Isolates display variable aggregation that may affect the relative virulence of strains. Therefore, dissection of this phenotype has gained substantial interest in recent years. We studied eight clinical isolates from four different clades (I-IV); four of which had a strongly aggregating phenotype and four of which did not. Genome analysis identified polymorphisms associated with loss of cell surface proteins were enriched in weakly-aggregating strains. Additionally, we identified down-regulation of chitin synthase and chitinase genes involved in the synthesis and dissolution of the chitinous septum. Characterisation of the cells revealed no ultrastructural defects in cytokinesis or cell separation in aggregating isolates. Strongly and weakly aggregating strains did not differ in net surface charge or in cell surface hydrophobicity. The capacity for aggregation and for adhesion to polystyrene microspheres were also not correlated. However, aggregation and extracellular matrix formation were all increased at higher growth temperatures, and treatment with the amyloid protein inhibitor Thioflavin-T markedly attenuated aggregation. Genome analysis further indicated strain specific differences in the genome content of GPI-anchored proteins including those encoding genes with the potential to form amyloid proteins. Collectively our data suggests that aggregation is a complex strain and temperature dependent phenomenon that may be linked in part to the ability to form extracellular matrix and cell surface amyloids. HIGHLIGHTSThe amyloid inhibitor Thioflavin-T inhibited C. auris aggregation. Aggregating isolates do not exhibit any defects in cell separation. Genomic differences were identified between strongly aggregating and weakly-aggregating strains of C. auris. Aggregation did not correlate with surface charge or hydrophobicity of yeast cells.

microbiology↗